Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.
Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.
- Chris Gibson, PhD
- Blake Borgeson, PhD
- Dean Li, PhD
- Today, we announced that Tim Ahfeldt, Ph.D., Irit Rappley, Ph.D. & Glenn Morrison, Ph.D. are joining the Recursion… https://t.co/KwXZrGLIj0
- Happy Thanksgiving! We're thankful for our incredible team of #Recursionauts working to positively impact patients… https://t.co/oLVsKrSE3G
- We’re hiring a Senior Product Manager, Digital Chemistry to translate company-level strategy into internal developm… https://t.co/rWVZH22bOr